A mass balance study of [14C]-lenalidomide following oral administration in healthy male subjects

被引：0
|
作者：
Chen, N. [1 ]
Kumar, G. [1 ]
Lau, H. [1 ]
Laskin, O. [1 ]
机构：
[1] Celgene Corp, Summit, NJ USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2008年 / 48卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
29
引用
收藏
页码：1105 / 1105
页数：1
相关论文
共 50 条
  • [41] A FIRST IN HUMAN TOPICAL STUDY TO CHARACTERIZE THE PHARMACOKINETICS (PK) FOLLOWING ADMINISTRATION OF [14C] UMECLIDINIUM (UMEC) TO THE AXILLA OR PALM OF HEALTHY MALE SUBJECTS.
    Dumitrescu, T. Pene
    Santos, L.
    Hughes, S.
    Pereira, A.
    Young, G.
    Hussey, E.
    Charlton, P.
    Baptiste-Brown, S.
    Stuart, J. S.
    Schmith, V. D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S39 - S40
  • [42] Absorption, metabolism, and excretion of [14C] imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects
    Ohmori, Satoshi
    Miura, Masahiro
    Toriumi, Chifuyu
    Satoh, Yoshiaki
    Ooie, Tsuyoshi
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (09) : 1624 - 1633
  • [43] Pharmacokinetics, mass balance, tissue distribution, metabolism, and excretion of [14C]aficamten following single oral dose administration to rats
    Grillo, Mark P.
    Sukhun, Rajaa
    Bashir, Mohammad
    Ashcraft, Luke
    Morgan, Bradley P.
    XENOBIOTICA, 2024, 54 (09) : 670 - 685
  • [44] Pharmacokinetics, excretion, and mass balance of 14C after administration of 14C-cholesterol-labeled AmBisome to healthy volunteers
    Bekersky, I
    Fielding, RM
    Dressler, DE
    Kline, S
    Buell, DN
    Walsh, TJ
    JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (09): : 963 - 971
  • [45] Pharmacokinetics and ADME Characterization After Oral and Intravenous Administration of [14C]-Ziftomenib in Healthy Male Participants
    Mitra, Amitava
    Ahsan, Julie Mackey
    Tabachri, Marilyn
    El-Shahat, Taha
    Leoni, Mollie
    Dale, Stephen
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2025, 18 (02):
  • [46] Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [14C]linezolid to healthy human subjects
    Slatter, JG
    Stalker, DJ
    Feenstra, KL
    Welshman, IR
    Bruss, JB
    Sams, JP
    Johnson, MG
    Sanders, PE
    Hauer, MJ
    Fagerness, PE
    Stryd, RP
    Peng, GW
    Shobe, EM
    DRUG METABOLISM AND DISPOSITION, 2001, 29 (08) : 1136 - 1145
  • [47] Absorption, Distribution, Metabolism and Excretion of [14C]Dexlansoprazole in Healthy Male Subjects
    Brian Grabowski
    Ronald D. Lee
    Clinical Drug Investigation, 2012, 32 : 319 - 332
  • [48] Absorption, Distribution, Metabolism and Excretion of [14C]Dexlansoprazole in Healthy Male Subjects
    Grabowski, Brian
    Lee, Ronald D.
    CLINICAL DRUG INVESTIGATION, 2012, 32 (05) : 319 - 332
  • [49] DISPOSITION OF [14C]ETRASIMOD FOLLOWING ORAL ADMINISTRATION TO HEALTHY MALE VOLUNTEERS AND ROLE OF CYP2C IN FORMATION OF OXIDATIVE METABOLITES.
    Lee, C.
    Oh, D.
    Tang, Y.
    Blackburn, A.
    Bloom, S.
    Cabell, C.
    Gilder, K.
    Grundy, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S65 - S65
  • [50] AN OPEN-LABEL, TWO-PERIOD STUDY DESIGNED TO EVALUATE AND COMPARE THE MASS BALANCE RECOVERY AND METABOLITE PROFILE OF 14C DEUTETRABENAZINE AND 14C-TETRABENAZINE IN HEALTHY MALE SUBJECTS
    Bradbury, Margaret
    Stamler, David
    Baillie, Thomas
    Mair, Stuart
    Sidhu, Sharan
    Wood, Stuart G.
    Shaw, Iain
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : S76 - S76
12345